Method for treating rhinitis and sinusitis by rhamnolipids
AssigneeRhamnopharma Inc.
InventorAnton Leighton
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods for treating rhinitis or sinusitis in a subject. In one embodiment, the method comprises the steps of: identifying a subject in need thereof, and administering intranasally to the subject a formulation comprising an only active ingredient of an effective amount of rhamnolipid. In another embodiment, the method comprises the steps of: identifying a subject in need thereof, and administering intranasally to the subject a first active ingredient of an effective amount of a rhamnolipid and a second active ingredient of an effective amount of a corticosteroid, an antihistamine, a leukotriene antagonist, cromylin, an antibiotic, a sphingolipid, or a decongestant.
Claims20
A method for treating rhinitis or sinusitis in a subject, comprising the steps of:
- identifying a subject suffering from rhinitis or sinusitis;
- administering intranasally to the subject a formulation comprising an only active ingredient of rhamnolipid in an effective amount, whereby the symptoms of rhinitis or sinusitis in the subject are reduced.
A method for treating rhinitis or sinusitis in a subject, comprising the steps of:
- identifying a subject suffering from rhinitis or sinusitis, and
- administering intranasally to the subject a first active ingredient of an effective amount of a rhamnolipid and a second active ingredient of an effective amount of a corticosteroid, an antihistamine, a leukotriene antagonist, a sphinogolipid, or a decongestant, whereby the symptoms of rhinitis or sinusitis in the subject are reduced.
Dependencies are inferred from the claim text.